Globus Medical (GMED) Tops Q3 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
Globus Medical (GMED) PT Raised to $80 at BofA Securities
November 6, 2024 5:57 AM ESTBofA Securities analyst Craig Bijou raised the price target on Globus Medical (NYSE: GMED) to $80.00 (from $55.00) while maintaining a Underperform rating.
The analyst comments "GMED continues to deliver beat and raises showing that it has managed the NuVasive integration better than... More
